ZEJULA
- Product NDC
- 69656-103
- 11-digit product format
- 696560103
- Labeler code
- 69656
- Product ID
- 69656-103_260fc974-c8bc-44c5-8f72-b2424254c10a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- niraparib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- GlaxoSmithKline LLC
- Application
- NDA208447
- Marketing category
- NDA
- Marketing start
- 2017-03-27
- Marketing end
- 0000-00-00
- Substance
- NIRAPARIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Poly(ADP-Ribose) Polymerase Inhibitor [EPC], Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69656-103-30 | 69656010330 | 30 CAPSULE in 1 BOTTLE (69656-103-30) | 30 capsule | 2018-07-01 | 0000-00-00 | No | No | Current |
| 69656-103-61 | 69656010361 | 30 CAPSULE in 1 BOTTLE (69656-103-61) | 30 capsule | 2020-07-01 | 0000-00-00 | Yes | No | Current |
| 69656-103-90 | 69656010390 | 90 CAPSULE in 1 BOTTLE (69656-103-90) | 90 capsule | 2017-03-27 | 0000-00-00 | No | No | Current |